Launch of the De-escalation Study Network: Why Cancer Care Needs More High‑Quality De-escalation Research
There is a strong need for more high‑quality de-escalation studies in cancer to enable more personalized treatment and improve patients’ quality of life.
Kristin Austlid Taskén, at the Institute for Cancer Research, and Ieva Ailte at the European Cancer Collaboration Unit at OUS are coordinating and leading the Task for Cancer Research in Work Package 8 of the Joint Action European Network of Comprehensive Cancer Centres (JA EUnetCCC, 2024–2028). This task focuses on planning and implementing networking activities related to research across cancer centres in Europe. One such activity is the launch of the De-escalation Study Network, which was initiated with the symposium “Innovating Cancer Care Through De-escalation Studies”, held at the Netherlands Cancer Institute on 5–6 March in Amsterdam.
The symposium gathered 125 participants, including clinicians, researchers, patient representatives, policymakers, and professionals from pharma and biotech, representing 25 countries. The symposium explored key challenges and requirements for launching successful de-escalation trials. It also identified obstacles to implementing de-escalation research in clinical practice, which should be addressed through joint efforts. Patients were invited to participate in the symposium both as speakers and as part of the panel debate and Q&A session.
You are welcome to join our De-escalation Study Network to receive information and invitations to future events by registering here:
Joining the EUnetCCC Cancer De-escalation Studies Network – Fill out form
News article from Oslo University Hospital (in Norwegian):
Behov for flere studier for å få mer persontilpasset kreftbehandling (oslo-universitetssykehus.no)
Listen to the podcast (in Norwegian) about what is de-escalation, why do we need it and how to enhance high quality de-escalation studies in Europe. The host – Elisabeth Kirkeng (RadForsk), Ieva Ailte (project manager EUnetCCC at OUS), Nina Adolfsen (patient representative) and Ole Alexander Opdalshei, Assistant Secretary
General of Kreftforeningen (Norwegian Cancer Society).
Podcast:
Hvordan utvikle enda mer persontilpasset kreftbehandling (spotify.com)
